Literature DB >> 3390789

Breast thermography. A prognostic indicator for breast cancer survival.

H J Isard1, C J Sweitzer, G R Edelstein.   

Abstract

A prognostic classification for thermographic staging of breast cancer has been applied to a cohort of 70 patients from 5040 screenees enrolled in the Albert Einstein Medical Center (AEMC) Breast Cancer Detection Demonstration Project (BCDDP). A diagnosis of breast cancer was established in each case before December 31, 1980. None of the patients have been lost to follow-up which extended from a minimum of 6 to a maximum of 13 years. Survival rates for those with favorable, equivocal, and poor thermographic factors are compared with each other and with results in accordance with tumor-node-metastasis (TNM) classification. As of December 31, 1986, there have been 22 (31.4%) deaths, all attributed to breast cancer. The thermographic scoring system clearly shows shorter survival for patients with poor thermographic prognostic factors, 30% surviving at 5 years and only 20% at 10 years compared with overall survival of 80% at 5 years and 70% at 10 years.

Entities:  

Mesh:

Year:  1988        PMID: 3390789     DOI: 10.1002/1097-0142(19880801)62:3<484::aid-cncr2820620307>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Relation between Locoregional Hyperthermic Area Detected by Contact Thermography and the Maximum Density of Tumor Stain Obtained by IV-DSA in Breast Cancer Patients.

Authors: 
Journal:  Breast Cancer       Date:  1996-03-29       Impact factor: 4.239

2.  Computer simulation in conjunction with medical thermography as an adjunct tool for early detection of breast cancer.

Authors:  Eddie Y-K Ng; N M Sudharsan
Journal:  BMC Cancer       Date:  2004-04-28       Impact factor: 4.430

3.  The association of infrared imaging findings of the breast with prognosis in breast cancer patients: an observational cohort study.

Authors:  Li-An Wu; Wen-Hung Kuo; Chin-Yu Chen; Yuh-Show Tsai; Jane Wang
Journal:  BMC Cancer       Date:  2016-07-27       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.